A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2012
At a glance
- Drugs Pentostatin (Primary)
- Indications Chronic lymphocytic leukaemia; Cutaneous T cell lymphoma; Lymphoproliferative disorders; Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 20 Jul 2009 Inclusion and exclusion criteria amended from NCT.
- 14 Jul 2009 Actual number of patients (60) added as reported by ClinicalTrials.gov.
- 06 Sep 2005 New trial record.